Metachromatic leukodystrophy without arylsulfatase A deficiency.
Two siblings of consanguinous parents were noted to have a neurologic syndrome marked by developmental delay, regression of psychomotor performance, marked spasticity and progressive central nervous system degeneration. Markedly delayed nerve conduction times and a sural nerve biopsy which demonstrated changes typical of metachromatic leukodystrophy (MLD) were evident. Impairment of sulfated glycolipid metabolism was documented by analysis of glycospingolipid in urinary sediment. In spite of these findings, activities of arylsulfatase A and cerebroside sulfatidase in white blood cells and cultured skin fibroblasts were near normal. However, when intact growing fibroblasts were loaded with 35SO4-sulfatide a clear defect in sulfatide cleavage, comparable to that seen in MLD patients, was observed. Thus, these patients represent a new form of sulfatide storage disease -- MLD characterized by intact enzyme activity in cell homogenates but defective sulfolipid metabolism in vivo and in intact fibroblasts.
D000328:Adult; D001192:Arylsulfatases / Q000378:metabolism*; D002553:Cerebroside-Sulfatase / Q000378:metabolism; D002648:Child; D002675:Child, Preschool; D005260:Female; D005347:Fibroblasts / Q000201:enzymology; D006028:Glycosphingolipids / Q000652:urine; D006801:Humans; D007962:Leukocytes / Q000201:enzymology; D007966:Leukodystrophy, Metachromatic / Q000201:enzymology* / Q000473:pathology / Q000652:urine; D008297:Male; D013429:Sulfatases / Q000378:metabolism*; D013497:Sural Nerve / Q000473:pathology
D006028:Glycosphingolipids; D013429:Sulfatases; D001192:Arylsulfatases; D002553:Cerebroside-Sulfatase